A web-based Continuing Medical Education (CME) activity that has been designed for healthcare professionals involved in the diagnosis and treatment of patients with acromegaly.

This educational series includes your choice of enduring CME activities based upon the fall 2005 live series:

-

-


Downloadable Monograph

One-hour long On-Demand slide presentation with associated audio featuring slides and audio from the live web-based programs.
Participation in either of these enduring activities will earn CME credit. Please see the accreditation section on the program website for complete information.

Program Overview:
Current information concerning the diagnosis and treatment of acromegaly that encompasses an evolving body of knowledge about a disease not commonly seen by most clinicians. Delays in diagnosis are common and clinicians are faced with a variety of therapeutic options for treatment. This program has been designed to review current information about the diagnosis and the management of acromegaly, with specific emphasis on recognition of subtle clinical symptoms resulting from the earliest exposure to excess Growth Hormone (GH) and Insulin-like Growth Factor I (IGF-I). The program will also address recently published data concerning the role of IGF-I in the management of acromegaly.


David Clemmons, MD

University of North Carolina
Chapel Hill, NC


Pamela Freda, MD Robert Gagel, MD Anne Klibanski, MD
  Columbia University
New York, NY		   University of Texas
M.D. Anderson Cancer Center
Houston, TX		   Harvard Medical School
Boston, MA

Registration:
To register or obtain more information regarding participation and accreditation of this activity including target audience, learning objectives and detailed course information, please see the program web site:

www.acromegalyupdate.com

Accreditation:
 This activity is jointly sponsored by Medical Education Collaborative (MEC) and CMM Global. MEC is a nonprofit organization that has been certifying quality educational activities since 1988. CMM Global is a private medical communications company committed to producing content of the highest integrity, quality and scientific foundation.
This program is supported by an unrestricted educational grant from Pfizer.

 


  
Questions? Contact CMM Global at acromegalyupdate@cmmglobal.com